Istituti Fisioterapici Ospitalieri Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00039208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Istituti Fisioterapici Ospitalieri - Roma

Active Ingredients

Drugs in Phase 4 Trials (1)

acitretin (soriatane) (1 trial)

Drugs in Phase 2 Trials (4)

fluorouracil (efudex) (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Psoriasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5